Holen Sie sich die Stockscreener-App
0.9714
1.16%
0.0111
Schlusskurs vom Vortag:
$0.9603
Offen:
$0.96
24-Stunden-Volumen:
2.07M
Relative Volume:
1.60
Marktkapitalisierung:
$131.24M
Einnahmen:
$46.74M
Nettoeinkommen (Verlust:
$-114.33M
KGV:
-1.6158
EPS:
-0.6012
Netto-Cashflow:
$-21.04M
1W Leistung:
+12.77%
1M Leistung:
+9.27%
6M Leistung:
+13.53%
1J Leistung:
-46.33%
1-Tages-Spanne:
$0.95
$1.01
1-Wochen-Bereich:
$0.90
$1.06
52-Wochen-Spanne:
$0.7316
$2.63
Scilex Holding Company Stock (SCLX) Company Profile
Firmenname
Scilex Holding Company
Sektor
Telefon
(650) 516-4310
Adresse
960 SAN ANTONIO ROAD, PALO ALTO
Scilex Holding Company Aktie (SCLX) Neueste Nachrichten
Scilex Pharmaceuticals announces end of phase II meeting with FDA for SP-103 - MSN
Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares - Investing.com India
Pleasing Signs As A Number Of Insiders Buy Scilex Holding Stock - Yahoo Finance
Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of - GlobeNewswire
Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, - Yahoo Finance
Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares By Investing.com - Investing.com Canada
Jaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat
Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock - ForexTV.com
Scilex Holding Company, Following its Prior Announcement of - GlobeNewswire
Scilex Holding Sets Dividend for Preferred Stock Exchange - TipRanks
Scilex Holding Company sets November 7, 2024 as the Record - GlobeNewswire
Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary - GlobeNewswire Inc.
Alliance Global Partners Begins Coverage on Scilex (NASDAQ:SCLX) - Defense World
Scilex gains on spinoff plans for pharma subsidiary - MSN
Scilex director Followwill Dorman buys $990 in common stock By Investing.com - Investing.com South Africa
Scilex director Followwill Dorman buys $990 in common stock - Investing.com
Scilex director Chun Jay acquires $4,750 in common stock - Investing.com
Holding Company Shares Rally Following Board Of Directors Commentary - MSN
Scilex Holding (NASDAQ:SCLX) Director Yue Alexander Wu Acquires 20,000 Shares - MarketBeat
Scilex holding's executive chairperson Ji Henry buys $9,710 in stock - Investing.com
Scilex director Wu Yue Alexander buys $18,992 in common stock By Investing.com - Investing.com South Africa
Scilex director Wu Yue Alexander buys $18,992 in common stock - Investing.com India
Scilex holding's executive chairperson Ji Henry buys $9,710 in stock By Investing.com - Investing.com UK
Scilex director Chun Jay acquires $4,750 in common stock By Investing.com - Investing.com Australia
Scilex CFO Stephen Hoi purchases $6,499 in common stock - Investing.com India
Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock - Investing.com India
Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock By Investing.com - Investing.com Canada
Jaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat
Scilex CFO Stephen Hoi purchases $6,499 in common stock By Investing.com - Investing.com UK
Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate - Benzinga
TSX Energy Capped Index (TTEN) QuotePress Release - The Globe and Mail
Scilex Holding looks to separate Scilex Pharma through potential spinout, IPO - FiercePharma
Scilex stock gains on spinoff plans (SCLX:NASDAQ) - Seeking Alpha
Scilex Holding explores spinoff for subsidiary Scilex Pharma - Investing.com
Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of securit - The Manila Times
Scilex Holding explores spinoff for subsidiary Scilex Pharma By Investing.com - Investing.com South Africa
Scilex Holding Company Announces that its Board of - GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Betwee - The Manila Times
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of - GlobeNewswire
Understanding the Risks of Investing in Scilex Holding Company (SCLX) - Knox Daily
Ratios Reveal: Breaking Down Scilex Holding Company (SCLX)’s Financial Health - The Dwinnex
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination - The Manila Times
SCLX: Financing Deal Puts Company in Good Shape - Smartkarma
SCLX Grows Sales and Improves Finances - MSN
Scilex Holding Company (NASDAQ: SCLX) Stock Could Be An Option To Consider - Stocks Register
Scilex Holding Company [SCLX] Records 200-Day SMA of $1.3991 - Knox Daily
Scilex reports growth in Q3 net sales for pain management products - Investing.com Australia
Scilex reports growth in Q3 net sales for pain management products By Investing.com - Investing.com South Africa
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024 - ForexTV.com
Oramed Pharmaceuticals Reinforces Scilex Financial Ties - TipRanks
Scilex Holding Company Provides Certain Preliminary - GlobeNewswire
Finanzdaten der Scilex Holding Company-Aktie (SCLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Scilex Holding Company-Aktie (SCLX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SHAH JAISIM | See Remarks |
Oct 29 '24 |
Buy |
0.99 |
32,000 |
31,670 |
109,333 |
| Followwill Dorman | Director |
Oct 18 '24 |
Buy |
0.99 |
1,000 |
990 |
2,300 |
| Chun Jay | Director |
Oct 18 '24 |
Buy |
0.95 |
5,000 |
4,750 |
112,500 |
| Wu Yue Alexander | Director |
Oct 17 '24 |
Buy |
0.95 |
20,000 |
18,992 |
25,000 |
| Lemus David | Director |
Oct 17 '24 |
Buy |
0.90 |
2,000 |
1,800 |
2,000 |
| Ji Henry | Executive Chairperson |
Oct 17 '24 |
Buy |
0.97 |
10,000 |
9,710 |
60,070 |
| SHAH JAISIM | See Remarks |
Oct 16 '24 |
Buy |
0.99 |
30,000 |
29,751 |
77,333 |
| Ma Stephen Hoi | Chief Financial Officer |
Oct 16 '24 |
Buy |
0.97 |
6,700 |
6,499 |
22,840 |
| Followwill Dorman | Director |
Jun 26 '24 |
Option Exercise |
1.37 |
1,000 |
1,370 |
1,300 |
| Wu Yue Alexander | Director |
Jun 20 '24 |
Option Exercise |
1.41 |
5,000 |
7,050 |
5,000 |
0.78%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):